CX3CR1 and diffuse large B-cell lymphoma: Therefore, this prospective study investigated the prognostic significance of CD11b+CX3CR1+ monocytes in peripheral blood (PB) and bone marrow (BM) on survival outcomes in newly-diagnosed DLBCL patients treated with R-CHOP immunochemotherapy.